Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-07-08 OYLER JOHN Chief Executive Officer Sale −719 $127.19 $91K 1,187
2019-07-08 OYLER JOHN Chief Executive Officer Sale −1,087 $127.89 $139K 100
2019-07-08 OYLER JOHN Chief Executive Officer Sale −100 $128.80 $13K 0
2019-07-01 Wang Xiaodong Director Sale −2,200 $126.13 $277K 2,647
2019-07-01 Wang Xiaodong Director Sale −2,647 $126.73 $335K 0
2019-06-27 Huang Jane CMO, Hematology Sale −427 $124.50 $53K 3
2019-06-27 Huang Jane CMO, Hematology Sale −3 $126.33 $379 0
2019-06-27 Liang Howard CFO & Chief Strategy Officer Sale −5,876 $9.47 $56K 122,317
2019-06-17 Yi Qingqing Director Other disposition −9,282 0
2019-06-06 BAKER BROS. ADVISORS LP Director Other disposition −182,539 1,028,034
2019-06-06 BAKER BROS. ADVISORS LP Director Other acquisition +13,516 20,618
2019-06-06 BAKER BROS. ADVISORS LP Director Other acquisition +13,516 20,618
2019-06-06 BAKER BROS. ADVISORS LP Director Other disposition −582,200 18,591
2019-06-06 BAKER BROS. ADVISORS LP Director Other acquisition +43,109 43,109
2019-06-06 BAKER BROS. ADVISORS LP Director Other acquisition +43,109 43,109
2019-06-05 Yi Qingqing Director Grant or award · Share Option (Right to Buy) +64,610 64,610
2019-06-05 Huang Jane CMO, Hematology Grant or award +62,842 334,463
2019-06-05 Huang Jane CMO, Hematology Grant or award · Share Option (Right to Buy) +462,579 462,579
2019-06-05 Wang Xiaodong Director Grant or award · Share Option (Right to Buy) +747,708 747,708
2019-06-05 Liang Howard CFO & Chief Strategy Officer Grant or award +75,855 128,193

Page 101 of 123 · 2,455 trades